Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome

Launched by SOHAG UNIVERSITY · Oct 19, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP) to treat obstructive jaundice in older patients, specifically those aged 65 and older. Obstructive jaundice is a condition that occurs when there is a blockage in the bile ducts, often caused by gallstones or cancer. The goal of the study is to understand how effective and safe ERCP is for older adults, as more and more elderly patients are experiencing these types of health issues.

To be eligible for this trial, participants need to be over 18 years old and diagnosed with obstructive jaundice. However, anyone who chooses not to participate will be excluded. If someone decides to join the study, they can expect to undergo ERCP, a procedure that involves using a flexible tube to access the bile ducts and potentially relieve the blockage. This trial is important because it aims to gather better evidence on how this procedure works for older patients, which can help improve treatment options in the future. The trial is not yet recruiting participants, but it highlights a growing need for effective care for elderly individuals facing these health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with obstructive jaundice older than 18 years old
• Exclusion Criteria:
• • patients who refuse consent
• • patients under 18 years old